Management Options for Refractory Chronic Myeloid Leukemia: Considerations for the ElderlyBRECCIA, Massimo; ALIMENA, Giuliana.Drugs & aging. 2013, Vol 30, Num 7, pp 467-477, issn 1170-229X, 11 p.Article

The significance of early, major and stable molecular responses in chronic myeloid leukemia in the imatinib eraBRECCIA, Massimo; ALIMENA, Giuliana.Critical reviews in oncology/hematology. 2011, Vol 79, Num 2, pp 135-143, issn 1040-8428, 9 p.Article

Tyrosine kinase inhibitors for elderly chronic myeloid leukemia patients: A systematic review of efficacy and safety dataBRECCIA, Massimo; TIRIBELLI, Mario; ALIMENA, Giuliana et al.Critical reviews in oncology/hematology. 2012, Vol 84, Num 1, pp 93-100, issn 1040-8428, 8 p.Article

Azacitidine for myelodysplastic patients aged > 65 years: a review of clinical efficacyBRECCIA, Massimo; MOLICA, Matteo; ZACHEO, Irene et al.Expert opinion on pharmacotherapy. 2014, Vol 15, Num 11, pp 1621-1630, issn 1465-6566, 10 p.Article

The importance of molecular monitoring in acute promyelocytic leukaemiaLO-COCO, Francesco; BRECCIA, Massimo; DIVERIO, Daniela et al.Baillière's best practice & research. Clinical haematology. 2003, Vol 16, Num 3, pp 503-520, issn 1521-6926, 18 p.Article

Efficacy of prolonged therapy with combined arsenic trioxide and ATRA for relapse of acute promyelocytic leukemiaBRECCIA, Massimo; CICCONI, Laura; MINOTTI, Clara et al.Haematologica (Roma). 2011, Vol 96, Num 9, pp 1390-1391, issn 0390-6078, 2 p.Article

Early hemorrhagic death before starting therapy in acute promyelocytic leukemia: association with high white blood cell count, late diagnosis and delayed treatment initiationBRECCIA, Massimo; LATAGLIATA, Roberto; CANNELLA, Laura et al.Haematologica (Roma). 2010, Vol 95, Num 5, pp 853-854, issn 0390-6078, 2 p.Article

Cutaneous pleomorphic T-cell lymphoma coexisting with myelodysplastic syndrome transforming into acute myeloid leukemia: successful treatment with a fludarabine-containing regimenBRECCIA, Massimo; PETTI, Maria Concetta; D'ELIA, Gianna Maria et al.European journal of haematology. 2002, Vol 68, Num 1, pp 1-3, issn 0902-4441Article

Granulocytic sarcoma of the pancreas successfully treated with intensive chemotherapy and stem cell transplantationBRECCIA, Massimo; D'ANDREA, Mariella; MENGARELLI, Andrea et al.European journal of haematology. 2003, Vol 70, Num 3, pp 190-192, issn 0902-4441, 3 p.Article

Dasatinib combined with weekly administration of vincristine as effective therapy in sudden or resistant Ph+ lymphoid blast crisis of chronic myeloid leukaemiaBRECCIA, Massimo; SERRAO, Alessandra; SALAROLI, Adriano et al.British journal of haematology. 2012, Vol 159, Num 5, pp 612-613, issn 0007-1048, 2 p.Article

Diagnostic value of detecting fusion proteins derived from chromosome translocations in acute leukaemiaLO-COCO, Francesco; BRECCIA, Massimo; NOGUERA, Nélida et al.Baillière's best practice & research. Clinical haematology. 2003, Vol 16, Num 4, pp 653-670, issn 1521-6926, 18 p.Article

Pregnancy in acute promyelocytic leukaemia after front-line therapy with arsenic trioxide and all-trans retinoic acidBRECCIA, Massimo; MOLICA, Matteo; EFFICACE, Fabio et al.British journal of haematology. 2014, Vol 167, Num 3, pp 428-430, issn 0007-1048, 3 p.Article

GIMEMA AIDA 0493 amended protocol for elderly patients with acute promyelocytic leukaemia. Long-term results and prognostic factorsLATAGLIATA, Roberto; BRECCIA, Massimo; MARTINELLI, Giovanni et al.British journal of haematology. 2011, Vol 154, Num 5, pp 564-568, issn 0007-1048, 5 p.Article

Hammersmith score application identifies chronic myeloid leukemia patients with poor prognosis before treatment with second-generation tyrosine kinase inhibitorsBRECCIA, Massimo; STAGNO, Fabio; MONTEFUSCO, Enrico et al.American journal of hematology. 2011, Vol 86, Num 6, pp 523-525, issn 0361-8609, 3 p.Article

Dasatinib, even at low doses, is an effective second-line therapy for chronic myeloid leukemia patients resistant or intolerant to imatinib. Results from a real life-based Italian multicenter retrospective study on 114 patientsVISANI, Giuseppe; BRECCIA, Massimo; PREGNO, Patrizia et al.American journal of hematology. 2010, Vol 85, Num 12, pp 960-963, issn 0361-8609, 4 p.Article

Sudden blast crisis in patients with philadelphia chromosome-positive chronic myeloid leukemia who achieved complete cytogenetic remission after imatinib therapyALIMENA, Giuliana; BRECCIA, Massimo; LATAGLIATA, Roberto et al.Cancer. 2006, Vol 107, Num 5, pp 1008-1013, issn 0008-543X, 6 p.Article

Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemiaLO-COCO, Francesco; CIMINO, Giuseppe; VENDITTI, Adriano et al.Blood. 2004, Vol 104, Num 7, pp 1995-1999, issn 0006-4971, 5 p.Article

Imatinib in Very Elderly Patients with Chronic Myeloid Leukemia in Chronic Phase: A Retrospective StudyLATAGLIATA, Roberto; FERRERO, Dario; TIRIBELLI, Mario et al.Drugs & aging. 2013, Vol 30, Num 8, pp 629-637, issn 1170-229X, 9 p.Article

Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, real-life experienceGIRMENIA, Corrado; MARIA FRUSTACI, Anna; BRECCIA, Massimo et al.Haematologica (Roma). 2012, Vol 97, Num 4, pp 560-567, issn 0390-6078, 8 p.Article

Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working PartyGUGLIOTTA, Gabriele; CASTAGNETTI, Fausto; GHERLINZONI, Filippo et al.Blood. 2011, Vol 117, Num 21, pp 5591-5599, issn 0006-4971, 9 p.Article

Achieving a major molecular response at thetime of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patientsIACOBUCCI, Ilaria; SAGLIO, Giuseppe; BASSAN, Renato et al.Clinical cancer research. 2006, Vol 12, Num 10, pp 3037-3042, issn 1078-0432, 6 p.Article

Granulocytic sarcoma with breast and skin presentation: A report of a case successfully treated by local radiation and systemic chemotherapyBRECCIA, Massimo; PETTI, Maria Concetta; FRATERNALI-ORCIONI, Giulio et al.Acta haematologica. 2000, Vol 104, Num 1, pp 34-37, issn 0001-5792Article

Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocolsBRECCIA, Massimo; MAZZARELLA, Luca; LATAGLIATA, Roberto et al.Blood. 2012, Vol 119, Num 1, pp 49-54, issn 0006-4971, 6 p.Article

Reduction of imatinib dose and persistence of complete molecular response after p210 multipeptide vaccine in chronic myeloid leukaemia treated with dose escalation for acquired resistanceBRECCIA, Massimo; BOCCHIA, Monica; CANNELLA, Laura et al.British journal of haematology. 2010, Vol 150, Num 2, pp 240-242, issn 0007-1048, 3 p.Article

Isolated molecular relapse in FIP1L1-PDGFRα hypereosinophilic syndrome after discontinuation and single weekly dose of imatinib : need of quantitative molecular procedures to modulate imatinib doseBRECCIA, Massimo; CILLONI, Daniela; CANNELLA, Laura et al.Cancer chemotherapy and pharmacology. 2009, Vol 63, Num 6, pp 1161-1163, issn 0344-5704, 3 p.Article